Phospho-ALK (Tyr1282/1283) Antibody (Rabbit mAb) [K9K20]

CatNo: F1494

    Application: Reactivity:
    • Lane 1: SUP-M2, Lane 2: SUP-M2 (CIP treated)
    1/

    当該製品は品切れ状态で、メールアドレスをご教示いただければ、お客様に返信いたします。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%

    使用情報

    Dilution
    1:1000
    1:100
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW Observed MW
    176 kDa 80 kDa (NPM-ALK), 220 kDa (ALK)
    *なぜ予測分子量と実際の分子量が異なるのか?
    下記の原因により、実際の分子量が予測と異なる:タンパク質の翻訳後修飾(リン酸化/糖鎖付加),スプライシングバリアント,イソフォーム,相対的な電荷,ポリマー。
    ポジティブコントロール SUP-M2 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail),and homogenize the tissue at a low temperature or lyse it by sonication on ice, then incubate on ice for 30 minutes.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail, Phosphatase Inhibitor Cocktail) , sonicate to lyse the cells, and incubate on ice for 30 minutes.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Add protein loading buffer to the 20 μL sample, and keep it on ice for immediate use; or determine the optimal denaturation conditions by boiling the sample at a temperature gradient (e.g., 37°C, 50°C, 70°C, 90°C, and 100°C). Cool the sample on ice and centrifuge for 5 min.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution ( recommending 5% BSA solution) for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    生物学的記述

    Specificity
    Phospho-ALK (Tyr1282/1283) Antibody (Rabbit mAb) [K9K20] detects endogenous levels of ALK protein only when phosphorylated at Tyr1282/1283.
    タンパク質の局在
    細胞膜、細胞内膜系
    Uniprot ID
    Q9UM73
    Clone
    K9K20
    Synonym(s)
    ALK; ALK receptor tyrosine kinase; ALK tyrosine kinase receptor; Anaplastic lymphoma kinase; anaplastic lymphoma receptor tyrosine kinase; CD246; CD246 antigen; mutant anaplastic lymphoma kinase; NBLST3
    Background
    Phospho-ALK (Tyr1282/1283) denotes the activated state of the anaplastic lymphoma kinase receptor in which two tyrosines within its activation loop are phosphorylated, a modification that is equivalent to Tyr342/343 in the oncogenic NPM–ALK fusion and marks catalytically engaged kinase capable of transmitting proliferative and survival signals. The ALK kinase domain follows the typical receptor tyrosine kinase fold with an activation loop containing Tyr1282 and Tyr1283, and phosphoproteomic mapping has identified these residues as key activation-loop phosphosites along with additional regulatory sites elsewhere in the kinase, defining a phospho-pattern that distinguishes inactive from signaling-competent ALK. Ligand binding or fusion-driven dimerization leads to ALK autophosphorylation within this activation loop, with phosphorylation of Tyr1282/1283 stabilizing the active conformation and creating docking surfaces for downstream effectors; antibodies that specifically recognize ALK only when phosphorylated at Tyr1282/1283 have shown that this state is present in select carcinoma cell lines and tumors and corresponds to strong downstream pathway activation. Once phosphorylated at Tyr1282/1283, ALK transduces signals through multiple cascades, prominently the Ras–ERK/MAPK axis, PI3K–Akt pathway and JAK–STAT signaling, leading to induction of genes that support cell-cycle progression, anti-apoptotic programs and invasive behavior. In neuroblastoma and other ALK-driven contexts, activated ALK robustly phosphorylates STAT3 on Tyr705, linking the Tyr1282/1283 activation-loop state to STAT3-dependent transcriptional programs that promote growth and resistance to stress. In NPM–ALK-positive anaplastic large-cell lymphoma and EML4–ALK-positive non-small cell lung cancer, constitutive activation-loop phosphorylation is sustained by fusion-mediated oligomerization, yielding phospho-ALK Tyr1282/1283 as a stable oncogenic signal that drives PLCγ, IRS‑1, Shc and PI3K activation and underpins the mitogenic and survival phenotypes of these fusion proteins. Mutational analysis of neighboring residues, such as ALK Y1278S, reveals that changes in the activation-loop region can produce ligand-independent phosphorylation of ALK itself and its downstream targets, indicating that phosphorylation at Tyr1282/1283 integrates with local sequence features to tune basal and induced kinase activity. Across tumor types, phospho-ALK Tyr1282/1283 serves as a functional biomarker of ALK pathway engagement: its detection correlates with responsiveness to ALK tyrosine kinase inhibitors and helps stratify tumors with ALK alterations in pan-cancer analyses, supporting its use to monitor target inhibition and emergent resistance in precision oncology.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください